{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:23:54Z","timestamp":1791699834153,"version":"4.3.4"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Long-term drug treatment for Restless Legs Syndrome (RLS) patients can frequently result in augmentation, which is the deterioration of symptoms with an increased drug dose. The cause of augmentation, especially derived from dopamine therapy, remains elusive. Here, we review recent research and clinical progress on the possible mechanism underlying RLS augmentation. Dysfunction of the dopamine system highly possibly plays a role in the development of RLS augmentation, as dopamine agonists improve desensitization of dopamine receptors, disturb receptor interactions within or outside the dopamine receptor family, and interfere with the natural regulation of dopamine synthesis and release in the neural system. Iron deficiency is also indicated to contribute to RLS augmentation, as low iron levels can affect the function of the dopamine system. Furthermore, genetic risk factors, such as variations in the <jats:italic>BTBD9<\/jats:italic> and <jats:italic>MEIS1<\/jats:italic> genes, have been linked to an increased risk of RLS initiation and augmentation. Additionally, circadian rhythm, which controls the sleep\u2013wake cycle, may also contribute to the worsening of RLS symptoms and the development of augmentation. Recently, Vitamin D deficiency has been suggested to be involved in RLS augmentation. Based on these findings, we propose that the progressive reduction of selective receptors, influenced by various pathological factors, reverses the overcompensation of the dopamine intensity promoted by short-term, low-dose dopaminergic therapy in the development of augmentation. More research is needed to uncover a deeper understanding of the mechanisms underlying the RLS symptom and to develop effective RLS augmentation treatments.<\/jats:p>","DOI":"10.3389\/fneur.2023.1160112","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T12:56:10Z","timestamp":1695905770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Exploring the causes of augmentation in restless legs syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Pengyu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101770","DOI":"10.1016\/j.smrv.2023.101770","article-title":"Attention deficit hyperactivity disorder and restless leg syndrome across the lifespan: a systematic review and meta-analysis","volume":"69","author":"Migueis","year":"2023","journal-title":"Sleep Med Rev"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/sleep\/32.8.1069","article-title":"Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders","volume":"32","author":"Cho","year":"2009","journal-title":"Sleep"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrneurol.2010.55","article-title":"Restless legs syndrome: pathophysiology, clinical presentation and management","volume":"6","author":"Trenkwalder","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1469-8749.2010.03796.x","article-title":"Prevalence and correlates of restless legs syndrome in adolescents","volume":"53","author":"Yilmaz","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11325-021-02353-9","article-title":"Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China","volume":"26","author":"Wang","year":"2022","journal-title":"Sleep Breath"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41572-021-00311-z","article-title":"Restless legs syndrome","volume":"7","author":"Manconi","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"j104","DOI":"10.1136\/bmj.j104","article-title":"New concepts in the management of restless legs syndrome","volume":"356","author":"Garcia-Borreguero","year":"2017","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"CD006009","DOI":"10.1002\/14651858.CD006009.pub2","article-title":"Dopamine agonists for restless legs syndrome","volume":"2011","author":"Scholz","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1212\/WNL.0000000000003388","article-title":"Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology","volume":"87","author":"Winkelman","year":"2016","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the first-line treatment of restless legs syndrome\/Willis\u2013Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation","volume":"21","author":"Garcia-Borreguero","year":"2016","journal-title":"Sleep Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archneur.1982.00510230065026","article-title":"Anterior spinal artery syndrome after cervical injection of heroin","volume":"39","author":"Fleishon","year":"1982","journal-title":"Arch Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.sleep.2006.09.009","article-title":"A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome","volume":"8","author":"Garcia-Borreguero","year":"2007","journal-title":"Sleep Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/mds.21050","article-title":"Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial","volume":"21","author":"Montplaisir","year":"2006","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"916","DOI":"10.4065\/79.7.916","article-title":"An algorithm for the Management of Restless Legs Syndrome","volume":"79","author":"Silber","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.mayocp.2020.12.026","article-title":"The Management of Restless Legs Syndrome: an updated algorithm","volume":"96","author":"Silber","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/bs.apha.2019.02.002","article-title":"Pharmacological treatments of augmentation in restless legs syndrome patients","volume":"84","author":"Trenkwalder","year":"2019","journal-title":"Adv Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"10:287","DOI":"10.1016\/j.jsmc.2015.05.020","article-title":"Dopaminergic augmentation in restless legs syndrome\/Willis-Ekbom disease: identification and management","author":"Garc\u00eda-Borreguero","year":"2015","journal-title":"Sleep Med Clin"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.smrv.2018.01.001","article-title":"Management of treatment failure in restless legs syndrome (Willis-Ekbom disease)","volume":"41","author":"Garcia-Borreguero","year":"2018","journal-title":"Sleep Med Rev"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e13632","DOI":"10.1111\/jsr.13632","article-title":"Restless legs syndrome: over 50\u2009years of European contribution","volume":"31","author":"Khachatryan","year":"2022","journal-title":"J Sleep Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.smrv.2009.11.006","article-title":"Dopaminergic augmentation of restless legs syndrome","volume":"14","author":"Garc\u00eda-Borreguero","year":"2010","journal-title":"Sleep Med Rev"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1303646","article-title":"Comparison of Pregabalin with Pramipexole for restless legs syndrome","volume":"370","author":"Allen","year":"2014","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.sleep.2011.03.003","article-title":"Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample","volume":"12","author":"Allen","year":"2011","journal-title":"Sleep Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/mds.24889","article-title":"Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks","volume":"27","author":"Garc\u00eda-Borreguero","year":"2012","journal-title":"Mov Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.sleep.2010.12.007","article-title":"Efficacy and augmentation during 6months of double-blind pramipexole for restless legs syndrome","volume":"12","author":"H\u00f6gl","year":"2011","journal-title":"Sleep Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.sleep.2008.04.012","article-title":"One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome","volume":"9","author":"Oertel","year":"2008","journal-title":"Sleep Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.sleep.2018.11.025","article-title":"Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment","volume":"55","author":"Garcia-Borreguero","year":"2019","journal-title":"Sleep Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.sleep.2010.11.002","article-title":"A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome","volume":"12","author":"Silver","year":"2011","journal-title":"Sleep Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/1531-8257(200101)16:1<144::AID-MDS1009>3.0.CO;2-F","article-title":"CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome","volume":"16","author":"Earley","year":"2001","journal-title":"Mov Disord"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","article-title":"Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease)","volume":"15","author":"Earley","year":"2014","journal-title":"Sleep Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/brain\/awp125","article-title":"Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome","volume":"132","author":"Connor","year":"2009","journal-title":"Brain"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"dmm049615","DOI":"10.1242\/dmm.049615","article-title":"Consensus guidelines on the construct validity of rodent models of restless legs syndrome","volume":"15","author":"Salminen","year":"2022","journal-title":"Dis Model Mech"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.brainresbull.2020.10.005","article-title":"Dopamine transporter is downregulated and its association with chaperone protein Hsc70 is enhanced by activation of dopamine D3 receptor","volume":"165","author":"Chang","year":"2020","journal-title":"Brain Res Bull"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1503\/jpn.110038","article-title":"Long-term administration of the dopamine D3\/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain","volume":"37","author":"Chernoloz","year":"2012","journal-title":"J Psychiatry Neurosci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nbd.2014.12.007","article-title":"Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake","volume":"74","author":"Castro-Hern\u00e1ndez","year":"2015","journal-title":"Neurobiol Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"105434","DOI":"10.1016\/j.phrs.2021.105434","article-title":"Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism","volume":"165","author":"Luis-Ravelo","year":"2021","journal-title":"Pharmacol Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jsmc.2015.05.022","article-title":"Restless leg syndrome\/Willis-Ekbom disease pathophysiology","volume":"10","author":"Allen","year":"2015","journal-title":"Sleep Med Clin"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.expneurol.2012.09.002","article-title":"Increased excitability of spinal pain reflexes and altered frequency-dependent modulation in the dopamine D3-receptor knockout mouse","volume":"238","author":"Keeler","year":"2012","journal-title":"Exp Neurol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1152\/jn.00849.2014","article-title":"Dopaminergic modulation of locomotor network activity in the neonatal mouse spinal cord","volume":"113","author":"Sharples","year":"2015","journal-title":"J Neurophysiol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.neuropharm.2012.11.032","article-title":"D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat","volume":"67","author":"Cruz-Trujillo","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1124\/mol.114.093096","article-title":"Functional selectivity of allosteric interactions within G protein\u2013coupled receptor oligomers: the dopamine D1-D3 receptor Heterotetramer","volume":"86","author":"Guitart","year":"2014","journal-title":"Mol Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.sleep.2017.10.001","article-title":"Long-term treatment with dopamine D3 receptor agonists induces a behavioral switch that can be rescued by blocking the dopamine D1 receptor","volume":"40","author":"Dinkins","year":"2017","journal-title":"Sleep Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev.neuro.27.070203.144206","article-title":"Desensitization of G protein-coupled receptors and neuronal functions","volume":"27","author":"Gainetdinov","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"9415","DOI":"10.1074\/jbc.M111811200","article-title":"Distinct residues in the carboxyl tail mediate agonist-induced desensitization and internalization of the human dopamine D1 receptor","volume":"277","author":"Lamey","year":"2002","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1210\/endo.138.10.5433","article-title":"Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells","volume":"138","author":"Ng","year":"1997","journal-title":"Endocrinology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.phrs.2019.03.003","article-title":"Biased signaling agonist of dopamine D3 receptor induces receptor internalization independent of \u03b2-arrestin recruitment","volume":"143","author":"Xu","year":"2019","journal-title":"Pharmacol Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/sleep\/27.4.669","article-title":"Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome","volume":"27","author":"Garcia-Borreguero","year":"2004","journal-title":"Sleep"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.archger.2011.06.002","article-title":"Prevalence and characteristics of restless legs syndrome (RLS) in the elderly and the relation of serum ferritin levels with disease severity: hospital-based study from Istanbul, Turkey","volume":"55","author":"\u00c7urgunlu","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.sleep.2007.07.020","article-title":"Augmentation in restless legs syndrome is associated with low ferritin","volume":"9","author":"Trenkwalder","year":"2008","journal-title":"Sleep Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejim.2019.02.009","article-title":"Iron supplementation for restless legs syndrome - a systematic review and meta-analysis","volume":"63","author":"Avni","year":"2019","journal-title":"Eur J Intern Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.sleep.2021.05.036","article-title":"Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia","volume":"84","author":"Bae","year":"2021","journal-title":"Sleep Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.sleep.2019.01.040","article-title":"Efficacy and tolerability of intravenous iron for patients with restless legs syndrome: evidence from randomized trials and observational studies","volume":"61","author":"Yang","year":"2019","journal-title":"Sleep Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1212\/CPJ.0000000000000276","article-title":"Restless legs syndrome with augmentation successfully treated with IV iron","volume":"7","author":"LaBarbera","year":"2017","journal-title":"Neurol Clin Pract"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/MCP.0b013e328365ab07","article-title":"Restless legs syndrome: update on pathogenesis","volume":"19","author":"Dauvilliers","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1474-4422(17)30327-7","article-title":"Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis","volume":"16","author":"Schormair","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11910-019-0965-4","article-title":"Update on restless legs syndrome: from mechanisms to treatment","volume":"19","author":"Gonzalez-Latapi","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.cub.2012.04.027","article-title":"Sleep fragmentation and motor restlessness in a Drosophila model of restless legs syndrome","volume":"22","author":"Freeman","year":"2012","journal-title":"Curr Biol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1111\/j.1537-2995.2012.03629.x","article-title":"A genetic risk factor for low serum ferritin levels in Danish blood donors","volume":"52","author":"S\u00f8rensen","year":"2012","journal-title":"Transfusion"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ana.22435","article-title":"Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis","volume":"70","author":"Catoire","year":"2011","journal-title":"Ann Neurol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1046\/j.1432-1327.1999.00549.x","article-title":"Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors","volume":"263","author":"Iwata","year":"1999","journal-title":"Eur J Biochem"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00429-020-02090-x","article-title":"BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome","volume":"225","author":"Lyu","year":"2020","journal-title":"Brain Struct Funct"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1093\/hmg\/dds221","article-title":"Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice","volume":"21","author":"DeAndrade","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fnbeh.2018.00199","article-title":"Differential dopamine D1 and D3 receptor modulation and expression in the spinal cord of two mouse models of restless legs syndrome","volume":"12","author":"Meneely","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fncir.2014.00062","article-title":"Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord","volume":"8","author":"Brewer","year":"2014","journal-title":"Front Neural Circuits"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/jnr.21207","article-title":"Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the a11 nucleus and dietary iron deprivation","volume":"85","author":"Zhao","year":"2007","journal-title":"J Neurosci Res"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"R485","DOI":"10.1016\/j.cub.2012.05.004","article-title":"Neurological disorders: towards a mechanistic understanding of restless legs syndrome","volume":"22","author":"Shaw","year":"2012","journal-title":"Curr Biol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11325-014-1049-y","article-title":"The effect of vitamin D supplements on the severity of restless legs syndrome","volume":"19","author":"Wali","year":"2015","journal-title":"Sleep Breath"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"557","DOI":"10.5664\/jcsm.7044","article-title":"The association between vitamin D level and restless legs syndrome: a population-based case-control study","volume":"14","author":"Wali","year":"2018","journal-title":"J Clin Sleep Med"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/MED.0000000000000199","article-title":"Vitamin D and anemia: insights into an emerging association","volume":"22","author":"Smith","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0006-8993(82)90331-6","article-title":"Chronic vitamin D deficiency in the weanling rat alters catecholamine metabolism in the cortex","volume":"242","author":"Baksi","year":"1982","journal-title":"Brain Res"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2147\/NDT.S63599","article-title":"Possible association between vitamin D deficiency and restless legs syndrome","volume":"10","author":"Oran","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5152\/cjms.2018.347","article-title":"Restless leg syndrome: role of Iron and vitamin D deficiencies. Cyprus","year":"2018","journal-title":"J Med Sci"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5334\/tohm.741","article-title":"Vitamin D and restless legs syndrome: a review of current literature","volume":"13","author":"Cederberg","year":"2023","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2016.10.007","article-title":"Introduction: towards a better understanding of the science of RLS\/WED","volume":"31","author":"Garcia Borreguero","year":"2017","journal-title":"Sleep Med"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.sleep.2004.01.007","article-title":"Circadian effects of dopaminergic treatment in restless legs syndrome","volume":"5","author":"Garcia-Borreguero","year":"2004","journal-title":"Sleep Med"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11910-002-0029-y","article-title":"Restless legs syndrome: a sensorimotor disorder of sleep\/wake motor regulation","volume":"2","author":"Hening","year":"2002","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/s1389-9457(02)00143-0","article-title":"Circadian aspects in the pathophysiology of the restless legs syndrome","volume":"3","author":"Garcia-Borreguero","year":"2002","journal-title":"Sleep Med"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ana.10843","article-title":"Circadian rhythm of restless legs syndrome: relationship with biological markers","volume":"55","author":"Michaud","year":"2004","journal-title":"Ann Neurol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.cell.2014.03.039","article-title":"Impact of circadian nuclear receptor REV-ERB\u03b1 on midbrain dopamine production and mood regulation","volume":"157","author":"Chung","year":"2014","journal-title":"Cells"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.sleep.2005.09.006","article-title":"Circadian changes in CSF dopaminergic measures in restless legs syndrome","volume":"7","author":"Earley","year":"2006","journal-title":"Sleep Med"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000048238","article-title":"Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment","volume":"75","author":"Khaldy","year":"2002","journal-title":"Neuroendocrinology"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1101\/2022.10.11.511837","article-title":"Polyphasic circadian neural circuits drive differential activities in multiple downstream rhythmic centers","volume":"33","author":"Liang","year":"2022"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"957193","DOI":"10.3389\/fnint.2022.957193","article-title":"Dopamine systems and biological rhythms: Let\u2019s get a move on","volume":"16","author":"Tang","year":"2022","journal-title":"Front Integr Neurosci"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pbb.2004.11.016","article-title":"Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2\/D3 receptor levels in mice","volume":"80","author":"Akhisaroglu","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1152\/japplphysiol.91076.2008","article-title":"Diurnal cycle influences peripheral and brain iron levels in mice","volume":"106","author":"Unger","year":"","journal-title":"J Appl Physiol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuroscience.2013.12.056","article-title":"Diurnal variations in brain iron concentrations in BXD RI mice","volume":"263","author":"Unger","year":"2014","journal-title":"Neuroscience"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/sleep\/31.6.847","article-title":"Altered iron metabolism in lymphocytes from subjects with restless legs syndrome","volume":"31","author":"Earley","year":"2008","journal-title":"Sleep"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12011-018-1442-7","article-title":"Iron deficiency reduces synapse formation in the Drosophila clock circuit","volume":"189","author":"Rudisill","year":"2019","journal-title":"Biol Trace Elem Res"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1242\/dmm.030080","article-title":"Meis1: effects on motor phenotypes and the sensorimotor system in mice","volume":"10","author":"Salminen","year":"2017","journal-title":"Dis Model Mech"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1160112\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T12:57:03Z","timestamp":1695905823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1160112\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":89,"alternative-id":["10.3389\/fneur.2023.1160112"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1160112","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"article-number":"1160112"}}